Literature DB >> 27693331

Targeting S1P Receptors, A New Mechanism of Action for Inflammatory Bowel Disease Therapy.

Giorgos Bamias1, Jesus Rivera-Nieves2.   

Abstract

Year:  2016        PMID： 27693331     DOI： 10.1053/j.gastro.2016.09.025

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

Review 1.  Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.

Authors:  Valerio Chiurchiù; Alessandro Leuti; Mauro Maccarrone
Journal:  Front Immunol       Date:  2018-01-29       Impact factor: 7.561

2.  Antibiotics promote the sampling of luminal antigens and bacteria via colonic goblet cell associated antigen passages.

Authors:  Kathryn A Knoop; Jenny K Gustafsson; Keely G McDonald; Devesha H Kulkarni; Rachel Kassel; Rodney D Newberry
Journal:  Gut Microbes       Date:  2017-03-07

3.  Plasma Levels of the Bioactive Sphingolipid Metabolite S1P in Adult Cystic Fibrosis Patients: Potential Target for Immunonutrition?

Authors:  Emina Halilbasic; Elisabeth Fuerst; Denise Heiden; Lukasz Japtok; Susanne C Diesner; Michael Trauner; Askin Kulu; Peter Jaksch; Konrad Hoetzenecker; Burkhard Kleuser; Lili Kazemi-Shirazi; Eva Untersmayr
Journal:  Nutrients       Date:  2020-03-14       Impact factor: 5.717
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.